New Paper: Maternal Consumption of Artificially Sweetened Beverages During Pregnancy is Associated with Infant Gut Microbiota and Metabolic Modifications and Increased Infant Body Mass Index
Congratulations to our Platform 2 Co-Lead Dr. Marie-Claire Arrieta and our Platform 4 Lead Dr. Laura Sycuro on this recent publication! Studying 100 infants from the CHILD Cohort Study, the authors aim to understand the link observed between the rise in childhood obesity and sweetener consumption during pregnancy. Abstract Artificial sweetener consumption by pregnant women […]
Mentorship Program
IMPACTT Mentorship Program About the Program Meet our Mentorship Cohorts Sign up for Updates About the Program Who is mentorship for? The IMPACTT mentorship program aims to support and advance the research careers of Senior Postdoctoral Fellows with at least three years of experience, scientists with other titles such as Research Associates who may not have […]
Ethics and Anti-Microbial Resistance (AMR)
The 5th volume of the Springer Series on Public Health Ethics Analysis published by Dr. Euzebiusz Jamrozik and Dr. Michael Selgelid, focuses on Ethics and Drug Resistance: Collective Responsibility for Global Public Health. The book explains and deciphers the rise of AMR and the problems arising along this race notably from an ethical point of […]
Learn About the CEGIIR: Biobank of Human Samples
The CEGIIR is a collection of human samples available to the research community. IMPACTT is leveraging the CEGIIR repository by helping researchers to access it. Dr. Madsen, Director of the CEGIIR Biobank is providing her support by informing the research community about the many samples available, guiding and assisting the researchers to obtain relevant samples. […]
CEGIIR Human Sample Biobank
CEGIIR Human Sample Biobank What is CEGIIR? The Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR) is associated with the Department of Medicine at the University of Alberta. CEGIIR is devoted to research on gastrointestinal and liver diseases, including inflammatory gastrointestinal disorders, non-ulcer dyspepsia, gastric infection with Helicobacter pylori, inflammatory bowel disease (IBD), […]
New Paper: From Birth to Overweight and Atopic Disease: Multiple and Common Pathways of the Infant Gut Microbiome
Congratulations to our Platform 2 Lead Dr. Anita Kozyrskyj on this recent publication! This recent study from Dr. Kozyrskyj’s team and colleagues highlights how birth factors from the CHILD study cohort (@CHILDSTUDY) correlate to changes in the gut microbes of infants to “determine the pathways by which these alterations may lead to an increased risk […]
